Latest News: 25 Million Dollar Wrongful Death Truck Verdict

BLOG TAG: birth injuries

News & Commentary

Anti-Epileptic Drug Depakote Linked To Birth Defects

Anti-Epileptic Drug Depakote Linked To Birth Defects

Since its first approval in 1983 for seizures, Depakote has been approved to treat various conditions. However, numerous studies conducted over the years have shown that women who take Depakote during pregnancy may have children that suffer from severe birth defects. Unfortunately, the drug’s labels may not have properly informed women of the risks. 

Depakote (valproic acid) is an antiepileptic drug that is also known as sodium valproate and divalproex sodium. It is similar to Depakene, which was approved for seizures in 1978. However, Depakote has an enteric coating to help reduce the gastrointestinal effects of the drug. Depakote was approved as follows:

  • Seizures (1983)
  • Bipolar disorder (1995)
  • Migraines (1996)
  • Extended Release version (2000)
  • Extended Release version and migraines (2005)
  • Generic version (2008)

Reports of a link between valproic acid and birth defects date back to 1980. Other studies followed, such as a report that estimated a 20-fold increased risk of spina bifida following in utero valproate exposure. Although use of valproic acid during pregnancy is most often associated with neural tube defects, other birth complications can include the following:

  • Cleft palates
  • Cardiac defects
  • Facial clefts
  • Hypospadias
  • Metopic craniosynostosis
  • Limb defects
  • Abnormal fingers and toes
  • Facial features such as small nose, depressed nasal bridge, thin upper lip, wide-set eyes, etc.

The complications listed above are symptoms of Fetal Valproate Syndrome, which the American Journal of Medicine studied in 1984. Over the years, researchers have continued studying the effects of valproic acid use during pregnancy. For instance, one study found a four-fold increase in congenital malformations among infants who were exposed to valproic acid compared to those who were exposed to other antiepileptic drugs. 

Additionally, researchers have found a link between prenatal valproic acid use and neurodevelopmental disorders in children. According to one study, “the risk of neurodevelopmental disorders was higher in children exposed to valproate monotherapy compared with control children,” and “autism spectrum disorder was the most frequent diagnosis.”  

In 2009, the New England Journal of Medicine published a study that followed epileptic pregnant women from 1999 to 2004 that took one of four anti-epileptic drugs: carbamazepine, lamotrigine, phenytoin, or valproate. Children exposed to Depakote in utero were found to have significantly lower IQ levels at age three than children exposed to other anti-epileptic drugs. The authors concluded that “[t]he present results, together with other data, suggest that valproate should not be used as a first-line antiepileptic drug in pregnant women or—since data indicate that half of pregnancies are unplanned—in women of childbearing potential.”    

In 2006, the FDA issued a Black Box warning for Depakote stating that valproic acid has a higher risk level than other antiepileptic drugs and can produce birth defects. 

Several issues have been identified with the Depakote label over time, including:

  • Pre-2006: No warning of increased birth defects compared to other drugs.
  • Pre-2010: No reference to cognitive, autism, or autism-spectrum disorders.
  • Pre-2011: No warning of increased risk of cognitive impairment or neurobehavioral issues.
  • Pre-2013: No warning of Pregnancy Category X for migraine and no warning of secondary therapy status for epilepsy and bipolar disorder.

If you believe your child has suffered birth defects due to the negligence of pharmaceutical companies, the attorneys at Newsome Melton LLP can help you seek the compensation—and justice—that and your family deserve.

 

Potential Birth Defects Might Lead to Zoloft Lawsuits

Potential Birth Defects Might Lead to Zoloft Lawsuits

A recent MSNBC article addressed the growing concern among pregnant women taking antidepressants during pregnancy and the connection to birth defects. According to MSNBC, a growing concern over the damage done by taking drugs like Zoloft in the third trimester of pregnancy has many women wondering if the anxiety relief is worth the risks to the developing infant.

Read more

Florida Decision Weekly Wrap-up 03/05

Florida Decision Weekly Wrap-up 03/05

FLORIDA BIRTH-RELATED NEUROLOGICAL INJURY COMPENSATION ASSOCIATION v. MICHAEL, Case No. 2D09-585. 2nd DCA. March 3, 2010.

[Torts. Birth-Related Neurological Injury Compensation Association]

Read more

Paxil birth defect lawsuits still mounting as GlaxoSmithKline shifts focus to other drugs

Paxil birth defect lawsuits still mounting as GlaxoSmithKline shifts focus to other drugs

Since 2005, the prescription anti-depression medicine Paxil and its parent company GlaxoSmithKline have been accused on a large scale of causing serious birth defects in children born to prescribed users of the drug. Hundreds of cases have been filed between 2005 and now, as women battling all forms of depression continued to use the drug while pregnant. Paxil was approved for prescription use by the Food and Drug Administration in 1999, and by 2005 the FDA had issued warnings that the drug may cause birth defects.

Read more
x
OVER $500,000,000 recovered
Newsome Melton has recovered over half a billion dollars for their clients.
Product Liability Lawyer - Newsome Melton

Please do not navigate away from this page until you receive a success notification.
Product Liability Lawyer - Newsome Melton